🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

SAMBA Trial: Towards a Paradigm Shift in Severe Asthma Management: Deep Analysis of the Effect of suBmaximal Aerobic Training

RecruitingNAAges 18 Years - 65 YearsAllUniversity of Liege
NCT04395937 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The effects of regular exercise on asthma control has not yet been well demonstrated. The aim of this study is to investigate the impact of submaximal aerobic training on exercise tolerance (VO2max - primary outcome) and a set of secondary outcomes: quality of life, asthma symptoms control, bronchial and systemic inflammatory markers, lung function, bronchial hyperresponsiveness, anxiety and depression and body composition in patients with persistant asthma.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * asthmatic patient * aged 18- 65 years * ACQ \> 1.5 * stable background treatment comprising at least one inhaled corticosteroid or an anti-leukotriene Exclusion Criteria: * IMC \> 35 * severe osteoarthritis of the knees and hips * unstable angor * Severe uncontrolled hypertension
💊

What it tests

  • Aerobic exercise training
  • Respiratory physiotherapy
📍

Where

1 site
Chu Liege
Liège, Belgium
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy